Recombinant INHBB antibodies are synthesized through:
Phage Display: Screening combinatorial libraries for high-affinity binders .
Hybridoma Sequencing: Cloning variable regions from existing murine/rabbit hybridomas .
Mammalian Transient Expression: HEK293F/CHO cells for scalable production .
Batch Consistency: Defined genetic sequences eliminate hybridoma instability .
High Specificity: Engineered via methods like affinity maturation .
Ethical Production: No reliance on animal sera or hybridoma cell lines .
Improved Sensitivity: Recombinant 46A/F antibody eliminates sample pre-treatment (e.g., H₂O₂ oxidation) required for earlier assays .
Cross-Reactivity: <0.5% with inhibin A, resolved through optimized epitope recognition .
Tumor Angiogenesis: INHBB promotes endothelial cell proliferation via TGF-β receptors (endoglin/ALK1), linked to ovarian and renal cancer progression .
Diagnostic Markers: Elevated INHBB correlates with poor survival in TP53-mutated ovarian cancers .
Assay Simplification: Recombinant 46A/F antibody eliminates overnight incubation and sample pretreatment, enabling rapid inhibin B quantification .
Tumor Microenvironment: INHBB-driven angiogenesis in ovarian cancers is mediated by endothelial endoglin/ALK1 signaling, suggesting therapeutic targets .
Cross-Reactivity: Earlier reports of 0.5% inhibin A cross-reactivity were reevaluated to <0.1% using high-purity recombinant standards .
The INHBB recombinant monoclonal antibody is produced through a meticulously designed in vitro process. Initially, INHBB antibody genes are extracted from B cells obtained from immunoreactive rabbits. These genes are subsequently amplified and incorporated into phage vectors. These vectors are then introduced into mammalian cell lines, facilitating the generation of functional antibodies in substantial quantities. The resulting INHBB recombinant monoclonal antibody is purified from the culture supernatant of the transfected cell lines utilizing affinity chromatography. This antibody demonstrates reactivity with human INHBB protein and has been rigorously validated for use in ELISA and FC applications.
INHBB plays a pivotal role in the formation of inhibin and activin, two hormone complexes that exert significant regulatory influence on the endocrine and reproductive systems. Moreover, they contribute to various aspects of embryonic development and tissue homeostasis. These multifaceted functions are crucial for maintaining hormonal equilibrium and ensuring the proper functioning of the reproductive system.
Inhibins and activins exert opposing actions on the secretion of follitropin by the pituitary gland. Inhibins inhibit, while activins activate, this process. These hormone complexes are involved in regulating a diverse array of biological functions, including hypothalamic and pituitary hormone secretion, gonadal hormone secretion, germ cell development and maturation, erythroid differentiation, insulin secretion, nerve cell survival, embryonic axial development, and bone growth. The specific functions of inhibins and activins are dependent on their subunit composition. Notably, inhibins generally counter the effects of activins.